公司資料
Catalyst Pharmaceutical 股價、新聞與催化劑
- 股票代碼:
- CPRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
31.49 USD (+0.03%)
收盤價
最後更新: 2026年7月14日
3.83B USD
市值
股價為何變動
Current closing-price context is not available for CPRX.
公司概覽
業務概覽
Catalyst Pharmaceuticals is a rare-neurology company focused on therapies for neuromuscular and orphan indications.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Catalyst sits in specialty biopharma.
商業模式特徵
The business combines commercial rare-disease revenue with a pipeline aimed at extending the franchise into additional orphan markets.
生技產業定位
Catalyst is a steady orphan-drug name whose stock is driven more by commercial execution than by broad pipeline risk.
未來催化劑
- Catalyst Pharmaceuticals's catalysts are Firdapse and AGAMREE execution, along with any rare-disease or label-expansion update that deepens the franchise. The business is still driven by commercial execution in orphan disease.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。